egfr s768i
Showing 1 - 1 of 1
NSCLC, EGFR G719X, EGFR L861Q Trial in Chongqing (Furmonertinib 160 mg, Q.D.)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Furmonertinib 160 mg, Q.D.
-
Chongqing, Chongqing, China
- +2 more
Sep 16, 2022